Correlation Between Tempest Therapeutics and Altamira Therapeutics
Can any of the company-specific risk be diversified away by investing in both Tempest Therapeutics and Altamira Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tempest Therapeutics and Altamira Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tempest Therapeutics and Altamira Therapeutics, you can compare the effects of market volatilities on Tempest Therapeutics and Altamira Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tempest Therapeutics with a short position of Altamira Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tempest Therapeutics and Altamira Therapeutics.
Diversification Opportunities for Tempest Therapeutics and Altamira Therapeutics
0.76 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Tempest and Altamira is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Tempest Therapeutics and Altamira Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Altamira Therapeutics and Tempest Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tempest Therapeutics are associated (or correlated) with Altamira Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Altamira Therapeutics has no effect on the direction of Tempest Therapeutics i.e., Tempest Therapeutics and Altamira Therapeutics go up and down completely randomly.
Pair Corralation between Tempest Therapeutics and Altamira Therapeutics
Given the investment horizon of 90 days Tempest Therapeutics is expected to under-perform the Altamira Therapeutics. In addition to that, Tempest Therapeutics is 1.04 times more volatile than Altamira Therapeutics. It trades about -0.15 of its total potential returns per unit of risk. Altamira Therapeutics is currently generating about -0.11 per unit of volatility. If you would invest 49.00 in Altamira Therapeutics on August 27, 2024 and sell it today you would lose (6.00) from holding Altamira Therapeutics or give up 12.24% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Tempest Therapeutics vs. Altamira Therapeutics
Performance |
Timeline |
Tempest Therapeutics |
Altamira Therapeutics |
Tempest Therapeutics and Altamira Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Tempest Therapeutics and Altamira Therapeutics
The main advantage of trading using opposite Tempest Therapeutics and Altamira Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tempest Therapeutics position performs unexpectedly, Altamira Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Altamira Therapeutics will offset losses from the drop in Altamira Therapeutics' long position.Tempest Therapeutics vs. Eliem Therapeutics | Tempest Therapeutics vs. HCW Biologics | Tempest Therapeutics vs. Scpharmaceuticals | Tempest Therapeutics vs. Milestone Pharmaceuticals |
Altamira Therapeutics vs. Eliem Therapeutics | Altamira Therapeutics vs. HCW Biologics | Altamira Therapeutics vs. Scpharmaceuticals | Altamira Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |